本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Annexon, Inc.

4.90
+0.10002.08%
盤後4.910.0100+0.20%18:59 EST
成交量:181.06萬
成交額:883.55萬
市值:7.08億
市盈率:-3.53
高:4.98
開:4.82
低:4.81
收:4.80
52周最高:5.66
52周最低:1.29
股本:1.45億
流通股本:1.28億
量比:0.55
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-1.3871
每股收益(LYR):-1.0058
淨資產收益率:-83.99%
總資產收益率:-44.95%
市淨率:4.39
市盈率(LYR):-4.87

資料載入中...

公司資料

公司名字:
Annexon, Inc.
交易所:
NASDAQ
成立時間:
2011
員工人數:
99
公司地址:
1400 Sierra Point Parkway,Building C,Suite 200,Brisbane,California,United States
郵編:
94005
電話:
傳真:
650 636 9773
簡介:
Annexon, Inc.於2011年3月3日根據特拉華州法律註冊成立。該公司是一家臨床階段生物製藥公司,致力於開發針對經典補體介導的身體,大腦和眼睛疾病的新型療法。

董事

名稱
職位
Douglas Love
President, Chief Executive Officer and Director
William D. Young
Chairman and Director
Carol Gallagher
Director
Emmett Cunningham
Director
Jung Choi
Director
Muneer A. Satter
Director
Ricky Sun
Director
Thomas G. Wiggans
Director

股東

名稱
職位
Douglas Love
President, Chief Executive Officer and Director
Jennifer Lew
Executive Vice President and Chief Financial Officer
Michael Overdorf
Executive Vice President and Chief Business Officer
Sanjay Keswani
Executive Vice President and Chief Medical Officer
Ted Yednock
Executive Vice President and Chief Scientific Officer